Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 14, 2022; 28(14): 1479-1493
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1479
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1479
Variables | Univariable analysis | Multivariable analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
ALT | 0.237 (0.043-1.292) | 0.096a | 0.159 (0.038-0.673) | 0.012a |
AST | 0.497 (0.100-2.471) | 0.393 | - | - |
Tumor size | 0.245 (0.059-1.019) | 0.053a | 0.243 (0.059-1.003) | 0.050a |
Tumor margin | 0.180 (0.046-0.706) | 0.014a | 0.170 (0.044-0.664) | 0.011a |
Radiomics | 3.473 (1.574-7.663) | 0.002a | 3.412 (1.562-7.453) | 0.002a |
- Citation: Che F, Xu Q, Li Q, Huang ZX, Yang CW, Wang LY, Wei Y, Shi YJ, Song B. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma. World J Gastroenterol 2022; 28(14): 1479-1493
- URL: https://www.wjgnet.com/1007-9327/full/v28/i14/1479.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i14.1479